The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.
Abstract | BACKGROUND: The need to better understand the molecular underpinnings of the heterogeneous outcomes of patients with prostate cancer is a pressing global problem and a key research priority for Movember. To address this, the Movember Global Action Plan 1 Unique tissue microarray (GAP1-UTMA) project constructed a set of unique and richly annotated tissue microarrays (TMA) from prostate cancer samples obtained from multiple institutions across several global locations. METHODS: Three separate TMA sets were built that differ by purpose and disease state. RESULTS: CONCLUSIONS: The GAP1-UTMA project has succeeded in combining a large set of tissue specimens from 501 patients with prostate cancer with rich clinical annotation. IMPACT:
|
Authors | Véronique Ouellet, Andrew Erickson, GAP1 UTMAs Contributing Investigators, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D True, Michael S Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O Osunkoya, Tracy Jones, G Steven Bova, Tarja Lamminen, Ariel H Achtman, Mark Buzza, Michelle M Kouspou, Steven A Bigler, Xinchun Zhou, Stephen J Freedland, Anne-Marie Mes-Masson, Isla P Garraway, Bruce J Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice S Knudsen, Angelo M De Marzo |
Journal | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
(Cancer Epidemiol Biomarkers Prev)
Vol. 31
Issue 4
Pg. 715-727
(04 01 2022)
ISSN: 1538-7755 [Electronic] United States |
PMID | 35131885
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | ©2022 The Authors; Published by the American Association for Cancer Research. |
Topics |
- Humans
- Male
- Prostate
(pathology)
- Prostatectomy
- Prostatic Neoplasms, Castration-Resistant
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|